The Genotype of the Donor for the (GT)_n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

• Víctor Noriega ,

  Contributed equally to this work with: Víctor Noriega, Carolina Martínez-Laperche

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• Carolina Martínez-Laperche ,

  Contributed equally to this work with: Víctor Noriega, Carolina Martínez-Laperche

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• Elena Buces,

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• Marjorie Pion,

  Affiliations Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain, Department of Inmunology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Noemí Sánchez-Hernández,

  Affiliation Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Beatriz Martín-Antonio,

  Affiliation Department of Hematology, Hospital Clinic, University of Barcelona, IDIBAPS, Instituto de Investigación Josep Carreras (IJC), Barcelona, Spain

  ⨯
• Vicent Guillem,

  Affiliation Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia, Universitat de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain

  ⨯
• Anna Bosch-Vizcaya,

  Affiliation Department of Hematology, ICO Girona, Hospital Josep Trueta, IDIBGI Foundation, Girona, Spain

  ⨯
• Leyre Bento,

  Affiliation Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Milagros González-Rivera,

  Affiliations Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain, DNA Sequencing Core Facility, Hospital General Universitario Gregorio Marañón, Madrid, Spain

  ⨯
• Pascual Balsalobre,

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• Mi Kwon,

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• David Serrano,

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• Jorge Gayoso,

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• Rafael de la Cámara,

  Affiliation Department of Hematology, Hospital La Princesa, Madrid, Spain

  ⨯
• Salut Brunet,

  Affiliation Department of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  ⨯
• Rafael Rojas-Contreras,

  Affiliation Department of Hematology, Hospital Reina Sofia, Cordoba, Spain

  ⨯
• José B. Nieto,

  Affiliation Department of Hematology, Hospital Morales Meseguer, Murcia, Spain

  ⨯
• Carmen Martínez,

  Affiliation Department of Hematology, Hospital Clínic, Barcelona, Spain

  ⨯
• Marcos Gónzalez,

  Affiliation Department of Hematology, University Hospital of Salamanca, Salamanca, Spain

  ⨯
• Ildefonso Espigado,

  Affiliation Department of Hematology and Hemotherapy, Hospital Universitario Virgen del Rocío, Seville, Spain

  ⨯
• Juan C. Vallejo,

  Affiliation Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain

  ⨯
• Antonia Sampol,

  Affiliation Department of Hematology, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, Spain

  ⨯
• Antonio Jiménez-Velasco,

  Affiliation Department of Hematology, Hospital Regional Universitario de Málaga, Málaga, Spain

  ⨯
• Alvaro Urbano-Ispizua,

  Affiliation Department of Hematology, Hospital Clinic, University of Barcelona, IDIBAPS, Instituto de Investigación Josep Carreras (IJC), Barcelona, Spain

  ⨯
• Carlos Solano,

  Affiliation Department of Hematology and Medical Oncology, Hospital Clínico Universitario de Valencia, Universitat de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain

  ⨯
• David Gallardo,

  Affiliation Department of Hematology, ICO Girona, Hospital Josep Trueta, IDIBGI Foundation, Girona, Spain

  ⨯
• José L. Díez-Martín,

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
• Ismael Buño ,

  * E-mail: ismaelbuno@gmail.com

  Affiliations Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

  ⨯
•  [ ... ],
• Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
• [ view all ]
• [ view less ]